Aldosterone as a modulator of immunity: implications in the organ damage.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Hypertension

• Publication date

  2011-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/HJH.0b013e32834a4c75PMID 21826023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ablation of Mineralocorticoid Receptors in Myocytes But Not in Fibroblasts Preserves Cardiac Function

  2011cited by this paper
• The mineralocorticoid receptor in heart: different effects in different cells.

  2011cited by this paper
• Interleukin 17 Promotes Angiotensin II–Induced Hypertension and Vascular Dysfunction

  2010cited by this paper
• Mineralocorticoid receptors, inflammation and sympathetic drive in a rat model of systolic heart failure

  2010cited by this paper
• T cells and blood vessels: costimulation turns up the pressure.

  2010cited by this paper
• Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages.

  2010cited by this paper
• Central neuronal activation and pressor responses induced by circulating ANG II: role of the brain aldosterone-"ouabain" pathway.

  2010cited by this paper
• Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice.

  2010cited by this paper
• Th17 Cells Facilitate the Humoral Immune Response in Patients with Acute Viral Myocarditis

  2010cited by this paper
• T lymphocytes: a role in hypertension?

  2010cited by this paper
• Central and Peripheral Mechanisms of T-Lymphocyte Activation and Vascular Inflammation Produced by Angiotensin II–Induced Hypertension

  2010cited by this paper
• The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses.

  2010cited by this paper
• Aldosterone-Induced Activation of Signaling Pathways Requires Activity of Angiotensin Type 1a Receptors

  2009cited by this paper
• Deletion of Mineralocorticoid Receptors From Macrophages Protects Against Deoxycorticosterone/Salt-Induced Cardiac Fibrosis and Increased Blood Pressure

  2009cited by this paper
• Aldosterone Promotes Autoimmune Damage by Enhancing Th17-Mediated Immunity

  2009cited by this paper
• Primary aldosteronism can alter peripheral levels of transforming growth factor β and tumor necrosis factor α

  2009cited by this paper
• Aldosterone induces arterial stiffness in absence of oxidative stress and endothelial dysfunction

  2009cited by this paper
• Corticosteroid receptors, macrophages and cardiovascular disease.

  2009cited by this paper
• Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha.

  2009cited by this paper
• Anti‐inflammatory effects of eplerenone on viral myocarditis

  2009cited by this paper
• Aldosterone-induced TGF-β1 Expression is Regulated by Mitogen-Activated Protein Kinases and Activator Protein-1 in Mesangial Cells

  2009cited by this paper
• Aldosterone Stimulates Elastogenesis in Cardiac Fibroblasts via Mineralocorticoid Receptor-independent Action Involving the Consecutive Activation of Gα13, c-Src, the Insulin-like Growth Factor-I Receptor, and Phosphatidylinositol 3-Kinase/Akt*

  2009cited by this paper
• Aldosterone and vascular inflammation.

  2008cited by this paper
• Intercellular Adhesion Molecule-1 Expression and Promote Leukocyte Adhesion Functional Mineralocorticoid Receptors in Human Vascular Endothelial Cells Regulate

  2008cited by this paper
• Statins Induce Regulatory T Cell Recruitment via a CCL1 Dependent Pathway1

  2008cited by this paper
• Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.

  2008cited by this paper
• Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction

  2007cited by this paper
• Aldosterone induces elastin production in cardiac fibroblasts through activation of insulin-like growth factor-I receptors in a mineralocorticoid receptor-independent manner.

  2007cited by this paper
• Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

  2006cited by this paper
• Transforming growth factor-beta induces development of the T(H)17 lineage.

  2006cited by this paper
• Mineralocorticoid receptor blockade but not steroid withdrawal reverses renal fibrosis in deoxycorticosterone/salt rats.

  2006cited by this paper
• Oxidative stress in aldosteronism.

  2006cited by this paper
• TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

  2006cited by this paper
• Plasma osteopontin levels are higher in patients with primary aldosteronism than in patients with essential hypertension.

  2006cited by this paper
• Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis.

  2006cited by this paper
• Angiotensin II and Aldosterone Regulate Gene Transcription Via Functional Mineralocortocoid Receptors in Human Coronary Artery Smooth Muscle Cells

  2005cited by this paper
• Simvastatin inhibits T‐cell activation by selectively impairing the function of Ras superfamily GTPases

  2005cited by this paper
• Tempol attenuates the development of hypertensive renal injury in Dahl salt-sensitive rats.

  2005cited by this paper
• Statins Suppress Oxidized Low Density Lipoprotein-induced Macrophage Proliferation by Inactivation of the Small G Protein-p38 MAPK Pathway*

  2005cited by this paper
• Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions.

  2005cited by this paper
• Andrographolide Interferes with T Cell Activation and Reduces Experimental Autoimmune Encephalomyelitis in the Mouse

  2005cited by this paper
• The aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) genes are not expressed in the rat heart.

  2005cited by this paper
• Control of aldosterone secretion: a model for convergence in cellular signaling pathways.

  2004cited by this paper
• Human Endothelium: Target for Aldosterone

  2004cited by this paper
• Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats.

  2004cited by this paper
• Statin-induced immunomodulatory effects on human T cells in vivo.

  2004cited by this paper
• Possible Contributions of Reactive Oxygen Species and Mitogen-Activated Protein Kinase to Renal Injury in Aldosterone/Salt-Induced Hypertensive Rats

  2004cited by this paper
• Origin of aldosterone in the rat heart.

  2004cited by this paper
• Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

  2004cited by this paper
• Aldosterone target organ protection by eplerenone.

  2004cited by this paper
• Primary Aldosteronism and Hypertensive Disease

  2003cited by this paper
• Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action.

  2003cited by this paper
• Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats.

  2003cited by this paper
• Hypertension and Left Ventricular Hypertrophy : The 4 E Effects of Eplerenone , Enalapril , and Eplerenone / Enalapril in Patients With Essential

  2003cited by this paper
• CD4+ T Cells Mediate Abscess Formation in Intra-abdominal Sepsis by an IL-17-Dependent Mechanism 1

  2003cited by this paper
• Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

  2003cited by this paper
• Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction

  2003cited by this paper
• Aldosteronism and Peripheral Blood Mononuclear Cell Activation: A Neuroendocrine-Immune Interface

  2003cited by this paper
• Aldosterone Is Produced From Ventricles in Patients With Essential Hypertension

  2002cited by this paper
• Aldosterone and d-Glucose Stimulate the Proliferation of Human Cardiac Myofibroblasts In Vitro

  2002cited by this paper
• Excess ldosterone Is Associated With Alterations of Myocardial Texture in Primary Aldosteronism

  2002cited by this paper
• Literature alert

  2002cited by this paper
• Aldosterone as a Mediator in Cardiovascular Injury

  2002cited by this paper
• Increased Carotid Wall Elastic Modulus and Fibronectin in Aldosterone-Salt–Treated Rats: Effects of Eplerenone

  2002cited by this paper
• Aldosterone induces a vascular inflammatory phenotype in the rat heart.

  2002cited by this paper
• Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy.

  2002cited by this paper
• Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein.

  2002cited by this paper
• Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

  2002cited by this paper
• Aldosterone-induced inflammation in the rat heart : role of oxidative stress.

  2002cited by this paper
• A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

  2001cited by this paper
• Multiple aspects of mineralocorticoid selectivity.

  2001cited by this paper
• Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton.

  2001cited by this paper
• Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease.

  2001cited by this paper
• Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure.

  2001cited by this paper
• Current perspectives on statins.

  2000cited by this paper
• Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.

  2000cited by this paper
• Microbial Lipopeptides Induce the Production of IL-17 in Th Cells1

  2000cited by this paper
• An alternatively spliced rat mineralocorticoid receptor mRNA causing truncation of the steroid binding domain.

  2000cited by this paper
• Cardiac Aldosterone Production in Genetically Hypertensive Rats

  2000cited by this paper
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

  2000cited by this paper
• Identification and role of aldosterone receptors in the cardiovascular system.

  2000cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• Rapid nongenomic effects of aldosterone in mineralocorticoid-receptor-knockout mice.

  1999cited by this paper
• Non‐genomic action of the mineralocorticoid aldosterone on cytosolic sodium in cultured kidney cells

  1998cited by this paper
• Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

  1998cited by this paper
• Vascular aldosterone in genetically hypertensive rats.

  1997cited by this paper
• Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion.

  1997cited by this paper
• Recent progress in understanding aldosterone secretion.

  1997cited by this paper
• Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells.

  1995cited by this paper
• Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart.

  1995cited by this paper
• Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.

  1993cited by this paper
• Myocardial fibrosis: role of angiotensin II and aldosterone.

  1993cited by this paper
• Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone.

  1993cited by this paper
• Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System

  1991cited by this paper
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality

  1991cited by this paper
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

  1990cited by this paper
• TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

  1989cited by this paper
• Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension.

  1984cited by this paper
• Mechanisms of salt and water retention in congestive heart failure. The importance of aldosterone.

  1960cited by this paper
• Spontaneous hypopotassemia, hypomagnesemia, alkalosis and tetany due to hypersecretion of corticosterone-like mineralocorticoid.

  1955cited by this paper

• Commentary on "Plasmacytoid dendritic cell content is associated with plasma aldosterone concentration in patients with primary aldosteronism".

  2025cites this paper
• Cell-Based Therapeutic Strategies for Autoimmune Diseases

  2025cites this paper
• Exploring the pathogenesis linking primary aldosteronism and obstructive sleep apnea via bioinformatic analysis

  2024cites this paper
• Primary hyperaldosteronism associated with type 3 autoimmune polyendocrine syndrome: A rare case report

  2024cites this paper
• A glucocorticoid-mediated immunoregulatory circuit integrated at brain levels: our early studies and a present view.

  2024cites this paper
• Associations between thyroid function, thyroid diseases, and primary aldosteronism.

  2024cites this paper
• The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice

  2023cites this paper
• Androgen aggravates aortic aneurysms via suppressing PD-1 in mice

  2023cites this paper
• Research Progress of the Relationship between Primary Aldosteronism and Thyroid Diseases

  2023cites this paper
• Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy

  2023cites this paper
• Perfect Homeostasis: pH

  2022cites this paper
• Divergent Characteristics of T-Cell Receptor Repertoire Between Essential Hypertension and Aldosterone-Producing Adenoma

  2022cites this paper
• Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus

  2022cites this paper
• Functional Characteristic and Significance of Aldosterone-Producing Cell Clusters in Primary Aldosteronism and Age-Related Hypertension

  2021cites this paper
• Adipose tissue macrophages as a therapeutic target in obesity‐associated diseases

  2021cites this paper
• Association of the Aldosterone Synthase Gene (CYP11B2) Polymorphic Locus rs1799998, c.–344C>T with the Development of Pulmonary Sarcoidosis

  2021cites this paper
• Glucocorticoid and mineralocorticoid receptor expression in critical illness: A narrative review

  2021cites this paper
• Proteomic profile of urinary extracellular vesicles identifies AGP1 as a potential biomarker of primary aldosteronism.

  2021cites this paper
• The Potential Role of Aldosterone-Producing Cell Clusters in Adrenal Disease

  2020cites this paper
• The Impact of Glucocorticoid Co-Secretion in Primary Aldosteronism on Thyroid Autoantibody Titers During the Course of Disease

  2020cites this paper
• Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course

  2020cites this paper
• Risk of new-onset autoimmune diseases in primary aldosteronism: a nation-wide population-based study.

  2019cites this paper
• Aldosterone in Gynecology and Its Involvement on the Risk of Hypertension in Pregnancy

  2019cites this paper
• Dendritic cells are crucial for cardiovascular remodeling and modulate neutrophil gelatinase-associated lipocalin expression upon mineralocorticoid receptor activation.

  2019cites this paper
• Dietary Fibers and Nutraceuticals in Prevention of Hypertension

  2019cites this paper
• Targeted treatment of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism.

  2019cites this paper
• Advances in the Development of Non-steroidal Mineralocorticoid-receptor Antagonists

  2019cites this paper
• Association of Papillary Thyroid Carcinoma with Primary Aldosteronism

  2018cites this paper
• Acute Cardiac Complications in Critical Brain Disease.

  2018cites this paper
• Tumor microenvironment in functional adrenocortical adenomas: immune cell infiltration in cortisol-producing adrenocortical adenoma.

  2018cites this paper
• Serum Cortisol and Cortisone as Potential Biomarkers of Partial 11&bgr;-Hydroxysteroid Dehydrogenase Type 2 Deficiency

  2018cites this paper
• Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives

  2018cites this paper
• Risk of sepsis in patients with primary aldosteronism

  2018cites this paper
• Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease

  2018cites this paper
• Coexistence of Primary Hyperaldosteronism and Graves' Disease, a Rare Combination of Endocrine Disorders: Is It beyond a Coincidence—A Case Report and Review of the Literature

  2017cites this paper
• Hypothesis on a relationship between hyperaldosteronism, inflammation, somatic mutations, and autoimmunity

  2017cites this paper
• Urinary Exosomes and Their Cargo: Potential Biomarkers for Mineralocorticoid Arterial Hypertension?

  2017cites this paper
• Rôle de la Neutrophil Gelatinase-Associated Lipocalin dans les effets cardiovasculaires et rénaux de l'activation du récepteur minéralocorticoïde. Spécificité et mécanismes d’action

  2017cites this paper
• β3-Adrenergic receptors, adipokines and neuroendocrine activation during stress induced by repeated immune challenge in male and female rats

  2017cites this paper
• Acute Cardiac Complications in Critical Brain Disease.

  2017cites this paper
• Finerenone: a New Mineralocorticoid Receptor Antagonist Without Hyperkalemia: an Opportunity in Patients with CKD?

  2016cites this paper
• Cardiac Dysfunction in Association with Increased Inflammatory Markers in Primary Aldosteronism

  2016cites this paper
• Ankylosing spondylitis associated with primary aldosteronism in a middle-aged woman

  2016cites this paper
• Pharmacological treatment of aldosterone excess.

  2015cites this paper
• Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology

  2015cites this paper
• Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone

  2015cites this paper
• Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation

  2014cites this paper
• Oxidative stress in patients affected by primary aldosteronism

  2014cites this paper
• Bone and Mineral Metabolism in Patients with Primary Aldosteronism

  2014cites this paper
• Spironolactone Decreases DOCA–Salt–Induced Organ Damage by Blocking the Activation of T Helper 17 and the Downregulation of Regulatory T Lymphocytes

  2014cites this paper
• The role of nutrition and nutraceutical supplements in the treatment of hypertension.

  2014cites this paper
• Hypertension: is it time to replace drugs with nutrition and nutraceuticals?

  2014cites this paper
• Autoimmunity in the pathogenesis of hypertension

  2014cites this paper
• Aldosterone Increases Early Atherosclerosis and Promotes Plaque Inflammation Through a Placental Growth Factor‐Dependent Mechanism

  2013cites this paper
• New Concepts in Cardiovascular Disease

  2013cites this paper
• Nutrition and Nutraceutical Supplements for the Treatment of Hypertension: Part I

  2013influential citation
• Positive association between aldosterone‐renin ratio and carotid intima‐media thickness in hypertensive children

  2013cites this paper
• Adrenal Histologic Findings Show No Difference in Clinical Presentation and Outcome in Primary Hyperaldosteronism

  2013cites this paper
• WITHDRAWN: Association between the levels of carboxy-terminal propeptide of type I procollagen and aldosterone in patients with primary aldosteronism and essential hypertension.

  2013cites this paper
• Primary aldosteronism - recent progress and current concepts.

  2013cites this paper
• Immune system alterations by aldosterone during hypertension: from clinical observations to genomic and non-genomic mechanisms leading to vascular damage.

  2013cites this paper
• Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke

  2012cites this paper
• The Ubiquitous Mineralocorticoid Receptor: Clinical Implications

  2012cites this paper
• Running title : Aldosterone and vascular damage in hypertensive children

  2012cites this paper
• Relationships of hardiness to physical and mental health status in military men: a test of mediated effects

  2011cites this paper